Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug manufacturing
Pharma
AstraZeneca-CSPC, FDA, NMPA—Fierce Pharma Asia
AstraZeneca penned a discovery pact with China's CSPC Pharma. The FDA halted new trials that export U.S. individuals' living cells to China. And more.
Angus Liu
Jun 20, 2025 11:28am
Trump rekindles pharmaceutical tariff threat: Reuters
Jun 17, 2025 11:21am
Senators bring back bill to bolster US pharma supply chain
Jun 17, 2025 8:40am
CDMO Resilience to streamline with the closing of 6 facilities
Jun 10, 2025 9:30am
Drugmakers, trade groups and others hit back on tariff threat
May 29, 2025 10:50am
Savara's lung disease asset hit with FDA refuse-to-file letter
May 27, 2025 10:35am